Physician profile
John Fish
NPI 1982819579
$57,707.83
in general payments reported to CMS, 2019-2025
29 companies · $2,391 in 2025
The $2,391 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $8,240 · 2021: $3,282 · 2022: $12K · 2023: $1,899 · 2024: $3,371 · 2025: $2,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,286 · Travel and Lodging: $2,410 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800 · Education: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,286.07 |
| Travel and Lodging | $2,409.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
| Education | $165.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $50,161.23 | 2019-2024 | Xarelto |
| Smith+Nephew, INC. | $3,468.79 | 2019-2025 | Pico, Versajet, Grafix |
| Tactile Systems Technology INC | $747.68 | 2019-2025 | Flexitouch Plus, Nimbl |
| E.R. Squibb & Sons, L.L.C. | $668.79 | 2019-2025 | Eliquis, Camzyos |
| Bard Peripheral Vascular, INC. | $529.80 | 2022-2024 | Venovo, Lutonix Drug Coated Balloon |
| Medtronic, INC. | $416.29 | 2021-2025 | Venaseal, Endurant Iis, Valiant Captivia |
| Pfizer INC. | $234.29 | 2022-2025 | |
| Kerecis Limited | $228.85 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Lemaitre Vascular, INC. | $192.00 | 2022-2023 | Xenosure Biologic Patch |
| Zimvie INC. | $149.85 | 2024 | |
| Janssen Scientific Affairs, LLC | $124.70 | 2021 | |
| Boston Scientific Corporation | $112.74 | 2020-2025 | Varithena Administration Pack |
| Novartis Pharmaceuticals Corporation | $108.72 | 2022-2025 | |
| Organogenesis INC. | $81.30 | 2023-2025 | Apligraf, Puraply |
| Medtronic Vascular, INC. | $76.85 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $67.67 | 2019-2022 | |
| Davol INC. | $59.36 | 2021-2022 | |
| Portola Pharmaceuticals, LLC | $57.23 | 2019 | |
| Angiodynamics, INC. | $43.22 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Mimedx Group, INC. | $36.57 | 2025 | |
| Integra Lifesciences Corporation | $31.42 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Inari Medical, INC. | $28.56 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $22.94 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $22.34 | 2025 | |
| Biocompatibles, INC. | $13.13 | 2019 | |
| W. L. Gore & Associates, INC. | $11.80 | 2019 | |
| Ethicon US, LLC | $11.71 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.